Guerbet (GRBT)

Currency in EUR
20.950
+0.250(+1.21%)
Closed·
GRBT Scorecard
Full Analysis
Valuation implies a strong free cash flow yield
GRBT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.95020.950
52 wk Range
17.60039.000
Key Statistics
Bid/Ask
20.45 / 21.40
Prev. Close
20.7
Open
20.95
Day's Range
20.95-20.95
52 wk Range
17.6-39
Volume
-
Average Volume (3m)
132
1-Year Change
-36.9%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GRBT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

Guerbet Company Profile

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine; Elucirem, a macrocyclic gadolinium-based contrast agent; and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; and Patent Blue V, a blue dye. Further, it offers Qitexio, a lipiodol resistant medical devices consisting of medical syringes and a stopcock; Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables, as well as HydraVision, a digital imaging system. Guerbet SA was incorporated in 1926 and is headquartered in Villepinte, France.

Employees
2842
Market
Germany

Compare GRBT to Peers and Sector

Metrics to compare
GRBT
Peers
Sector
Relationship
P/E Ratio
16.4x15.6x−0.5x
PEG Ratio
−0.50−0.020.00
Price/Book
0.7x2.8x2.6x
Price / LTM Sales
0.3x2.6x3.3x
Upside (Analyst Target)
-53.3%43.4%
Fair Value Upside
Unlock−0.2%7.1%Unlock

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
-- / --
Revenue / Forecast
180.10M / --
EPS Revisions
Last 90 days

GRBT Income Statement

People Also Watch

70.32
TEPRF
-0.20%
252.90
ESLX
+0.28%
27.51
DAST
-0.25%
21.77
STMPA
+1.92%
70.75
LTEN
+2.09%

FAQ

What Stock Exchange Does Guerbet Trade On?

Guerbet is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Guerbet?

The stock symbol for Guerbet is "GRBT."

What Is the Guerbet Market Cap?

As of today, Guerbet market cap is 263.41M.

What Is Guerbet's Earnings Per Share (TTM)?

The Guerbet EPS (TTM) is 1.28.

When Is the Next Guerbet Earnings Date?

Guerbet will release its next earnings report on 23 Sept 2025.

From a Technical Analysis Perspective, Is GRBT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Guerbet Stock Split?

Guerbet has split 1 times.

How Many Employees Does Guerbet Have?

Guerbet has 2842 employees.

What is the current trading status of Guerbet (GRBT)?

As of 10 Aug 2025, Guerbet (GRBT) is trading at a price of 20.95, with a previous close of 20.70. The stock has fluctuated within a day range of 20.95 to 20.95, while its 52-week range spans from 17.60 to 39.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.